Polynucleotides encoding BSL2v1c2-Ig

Details Polynucleotides encoding BSL2v1c2-Ig Polynucleotides encoding BSL2v1c2-Ig

2008-05-06

2008-05-06

Ouspenski, Ilia (Department: 1644)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S023100, C536S023400, C536S023530, C435S320100, C435S252300, C435S455000, C435S069100

Reexamination Certificate

active

07368554

ABSTRACT:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

REFERENCES:
patent: 6630575 (2003-10-01), Coyle et al.
patent: 6635750 (2003-10-01), Coyle et al.
patent: 2002/0106730 (2002-08-01), Coyle et al.
patent: 2004/0137577 (2004-07-01), Coyle et al.
patent: 2004/0162236 (2004-08-01), Alsobrook et al.
patent: 2004/0236088 (2004-11-01), Heuer et al.
patent: 1067182 (2001-01-01), None
patent: 1074617 (2001-02-01), None
patent: WO9819706 (1998-05-01), None
patent: WO98/58965 (1998-12-01), None
patent: WO9946281 (1999-03-01), None
patent: WO 99/46281 (1999-09-01), None
patent: WO9947558 (1999-09-01), None
patent: EP1074617 (2000-07-01), None
patent: WO 00/55375 (2000-09-01), None
patent: WO0053756 (2000-09-01), None
patent: WO 00/61612 (2000-10-01), None
patent: WO 00/68266 (2000-11-01), None
patent: WO0068266 (2000-11-01), None
patent: WO 01/18021 (2001-03-01), None
patent: WO 01/18022 (2001-03-01), None
patent: WO 01/18204 (2001-03-01), None
patent: WO0114556 (2001-03-01), None
patent: WO0114566 (2001-03-01), None
patent: WO0114577 (2001-03-01), None
patent: WO0121631 (2001-03-01), None
patent: WO0134629 (2001-05-01), None
patent: WO0134768 (2001-05-01), None
patent: WO0139722 (2001-06-01), None
patent: EP1130094 (2001-09-01), None
patent: WO0168848 (2001-09-01), None
patent: WO0183750 (2001-11-01), None
patent: WO0200692 (2002-01-01), None
patent: WO0200730 (2002-01-01), None
patent: WO0208279 (2002-01-01), None
patent: WO0210187 (2002-02-01), None
patent: WO0222683 (2002-03-01), None
patent: WO02097046 (2002-12-01), None
patent: WO03/014293 (2003-02-01), None
patent: WO03085124 (2003-10-01), None
patent: WO2004093894 (2004-11-01), None
Castriconi, et al., “Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis”, PNAS, vol. 101(34), pp. 12640-12645 (2004).
Collins, et al., “The B7 family of immune-regulatory ligands”, Genome Biol., vol. 6, pp. 223.1-223.7 (2005).
Dong, et al., “Immune Regulation by Novel Costimulatory Molecules”, Immunologic Res., vol. 28(1), pp. 39-48 (2003).
Ferlazzo, et al., “T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties”, Eur. J. Immunol., vol. 32, pp. 3092-3101 (2002).
Greenwald, et al., “The B7 Family Revisited”, Annu. Rev. Immunol., vol. 23, pp. 515-548 (2005).
Kim, et al., “Constitutive and Inducible Expression of B7 Family of Ligands by Human Airway Epithelial Cells”, Am. J. Respir. Cell Mol. Biol., vol. 33, pp. 280-289 (2005).
Lane, et al., “mRNA For Genes Associated with Antigen Presentation are Expressed by Human Middle Meatal Epithelial Cells in Culture”, The Laryngoscope, vol. 114, pp. 1827-1832 (2004).
Ling, et al., “Duplication of primate and rodent B7-H3 immunoglobulin V- and C- like domains: divergent history of functional redundancy and exon loss”, Genomics, vol. 82, pp. 365-377 (2003).
Loke, et al., Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells, Arthrits Res. Therapy, vol. 6(5), pp. 208-214 (2004).
Luo, et al., “B7-H3 Enhances Tumor Immunity In Vivo by Costimulating Rapid Clonal Expansion of Antigen-Specific CD8+Cytolytic T Cells”, J. Immunol., vol. 173, pp. 5445-5450 (2004).
Petroff, et al., “The Immunomodulatory Proteins B7-DC, By-H2, and B7-H3 Are Differentially Expressed across Gestation in the Human Placenta”, Amer. J. Pathology, vol. 167(2), pp. 465-473 (2005).
Prasad, et al., “Murine B7-H3 Is a Negative Regulator of T Cells”, J. Immunol., vol. 173, pp. 2500-2506 (2004).
Saatian, et al., “Expression of genes for B7-H3 and other T cell ligands by nasal epithelial cells during differentiation and activation”, Am. J. Physiol. Lung Cell Mol. Physiol., vol. 287, pp. L127-L224 (2004).
Steinberger, et al., “Molecular Characterization of Human 4Ig-B7-H3, a Member of the B7 Family with Four Ig-Like Domains”, J. Immunol., vol. 172, pp. 2352-2359 (2004).
Suh, et al., “The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses”, Nature Immunol., vol. 4(9), pp. 899-906 (2003).
Suh, et al., “The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization”, PNAS, vol. 101(35), pp. 12969-12973 (2004).
Sun, et al., “Mouse B7-H3 induces antitumor immunity”, Gene Therapy, vol. 10, pp. 1728-1734 (2003).
Thomas, et al., “A Cell-Based Artificial Antigen-Presenting Cell Coated with Anti-CD3 and CD28 Antibodies Enables Rapid Expansion and Long-Term Growth of CD4 T Lymphocytes”, Clinical Immunol., vol. 105(3), pp. 259-272 (2002).
Wang, et al., “Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses”, Microbes Infection, vol. 6, pp. 759-766 (2004).
Wang, et al., “B7-H3 promotes acute and chronic allograft rejection”, Eur. J. Immunol., vol. 36, pp. 428-438 (2005).
Zhang, et al., “Human Recombinant B7-H3 Expressed inE. coliEnhances T Lymphocyte Proliferation and Il-10 Secretion in Vitro”, Acta Biochimica Biophysica Sinica, vol. 36(6), pp. 430-436 (2004).
Finck, et al., “Treatment of Murine Lupus with CTLA4Ig”, Science vol. 265, po. 1225-1227 (1994).
Kremer, et al., “Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig”, N Engl. J. Med., vol. 349(20), pp. 1907-1915 (2003).
Tan, et al., “Induction of Alloantigen-specific Hyporesponsiveness in Human T Lymphocytes by Blocking Interaction of CD28 with Its Natural Ligand B7/BB1”, J. Exp. Med., vol. 177, pp. 165-173 (1993).
Webb, et al., “Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2”, Eur. J. Immunol., vol. 26, pp. 2320-2328 (1996).
NCBI Entrez Accession No. gi|7023409, T. Isogai et al., Feb. 22, 2000.
NCBI Entrez Accession No. gi|13376850, Y. Latchman et al., Mar. 18, 2001.
NCBI Entrez Accession No. gi|13376852, A.I. Chapoval et al., Mar. 18, 2001.
NCBI Entrez Accession No. gi|13640665, NCBI Annotation Project, Oct. 16, 2001.
NCBI Entrez Accession No. gi|14741794, NCBI Annotation Project, Aug. 27, 2001.
NCBI Entrez Accession No. gi|16160937, NCBI Annotation Project, Oct. 16, 2001.
NCBI Entrez Accession No. gi|22760560, T. Isogai et al., Sep. 3, 2002.
NCBI Entrez Accession NO. gi|22761770, T. Ota et al., Sep. 3, 2002.
M.W. Biggs et al., “Suppression of immune surveillance in melanoma”, Medical Hypotheses, vol. 56, No. 6, pp. 648-652 (2001).
C.C. Bleul et al., “Laser capture microdissection-based expression profiling indentifies PD1-ligand as a target of the nude locus gene product”, Eur. J. Immunol., vol. 31, pp. 2497-2503 (2001).
L.L. Carter et al., “PD-1:PD-L inhibitory pathway affects both CD4+and CD8+T cellas and is overcome by IL-2”, Eur. J. Immunol., vol. 32, pp. 634-643 (2002).
H. Dong et al., “B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 s

Affiliated with

Also associated with

Rating

Polynucleotides encoding BSL2v1c2-Ig does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polynucleotides encoding BSL2v1c2-Ig, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotides encoding BSL2v1c2-Ig will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2779968